Visceral obesity without insulin resistance in late-onset obesity rats

Endocrinology

Volumn 145, Issue 6, 2004, Pages 2666-2679

  Bains, Randip K ^a   Wells, Sara E ^b   Flavell, Dave M ^c   Fairhall, Keith M ^a   Strom, Molly ^a   Le Tissier, Paul ^a   Robinson, Iain C A F ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CORTICOSTERONE; INSULIN; ROSIGLITAZONE; TETRAHYDROLIPSTATIN;

ADIPOCYTE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL COUNT; CELL SIZE; CONTROLLED STUDY; DIET RESTRICTION; ESTROGEN THERAPY; FAT INTAKE; FEMALE; GENETIC ANALYSIS; GENETIC CODE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID STORAGE; LOW FAT DIET; MALE; MITOCHONDRION; NONHUMAN; OBESITY; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; RAT; RIBOSOME; TRANSGENE; TRANSGENIC ANIMAL; VISCERA; WEIGHT GAIN;

ABSORPTION; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BODY TEMPERATURE; DIET; DIETARY FATS; DISEASE SUSCEPTIBILITY; EATING; ESTRADIOL; FEMALE; GLUCOSE; GROWTH HORMONE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; OVARIECTOMY; PHENOTYPE; RATS; RATS, WISTAR; THIAZOLIDINEDIONES; TIME FACTORS; VISCERA;

EID: 2542419065     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1608     Document Type: Article

References (74)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79
2. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C 2002 The human obesity gene map: the 2001 update. Obes Res 10:196-243
3. Comuzzie AG, Allison DB 1998 The search for human obesity genes. Science 280:1374-1377
4. Perusse L, Chagnon YC, Weisnagel J, Bouchard C 1999 The human obesity gene map: the 1998 update. Obes Res 7:111-129
5. Chagnon YC, Perusse L, Weisnagel SJ, Rankinen T, Bouchard C 1999 The human obesity gene map: the 1999 update. Obes Res 8:89-117
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
7. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271
8. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP 1996 Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495
9. Ingalls AM, Dickie MM, Snell GD 1950 Obesity, new mutation in the mouse. J Hered 41:317-318
10. Hummel KP, Dickie MM, Coleman DL 1966 Diabetes, a new mutation in the mouse. Science 153:1127-1128
11. Coleman DL, Eicher EM 1990 Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 81:424-427
12. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP 1995 Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 92:4728-4732
13. Huszar D, Lynch CA, Fairchild HV, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
14. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
15. Wells SE, Flavell DM, Bisset GW, Houston PA, Christian H, Fairhall KM, Robinson IC 2003 Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurons. J Physiol 551:323-336
16. Charlton HM, Clark RG, Robinson IC, Goff AE, Cox BS, Bugnon C, Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119:51-58
17. Clark RG, Mortensen DL, Carlsson LM, Carlsson B, Cannignac D, Robinson IC 1996 The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 137:1904-1912
18. Russell JC, Graham SE, Dolphin PJ 1999 Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). Metabolism 48:701-706
19. Cavdar Koc E, Burkhart W, Blackburn K, Moseley A, Spremulli LL 2001 The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present. J Biol Chem 276:19363-19374
20. Spiegelman BM, Flier JS 1996 Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389
21. Chua S, Leibel RL 1997 Obesity genes: molecular and metabolic mechanisms. Diebetes Rev 5:2-7
22. Levine AS, Billington CJ 1998 Obesity: progress through genetic manipulation. Curr Biol 8:R251-R252
23. York DA, Hansen B 1998 Animal models of obesity. In: Bray GA, Bouchard C, James WPT, eds. Handbook of obesity. New York: Marcel Dekker; 191-221
24. Inui A 2000 Transgenic approach to the study of body weight regulation. Pharmacol Rev 52:35-61
25. Hummel KP, Dickie MM, Coleman DL 1966 Diabetes, a new tradition in the mouse. Science 153:1127-1128
26. Coleman DL, Hummel KP 1967 Studies with the mutation, diabetes, in the mouse. Diabetologia 3:238-248
27. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW 1982 Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260
28. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G 1990 The response to long-term overfeeding in identical twins. N Engl J Med 322:1477-1482
29. Kannel WB, Cupples LA, Ramaswami R, Stokes III J, Kreger BE, Higgins M 1991 Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 44:183-190
30. Colombel A, Charbonnel B 1997 Weight gain and cardiovascular risk factors in the post-menopausal women. Hum Reprod 1:134-145
31. West DB, Prinz WA, Greenwood MR 1989 Regional changes in adipose tissue blood flow and metabolism in rats after a meal. Am J Physiol:R711-R716
32. Santos RF, Sztalryd C, Reaven G 1991 Effect of anatomical site on insulin action and insulin receptor phosphorylation in isolated rat adipocytes. Int J Obes 15:755-762
33. Tavernier G, Galitzky J, Valet P, Remaury A, Bouloumie A, Lafontan M, Langin D 1995 Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes. Am J Physiol 268(6 Pt 1):E1135-E1142
34. Marin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjostrom L, Bjorntorp P 1992 The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 41:1242-1248
35. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
36. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90
37. Bjorntorp P 1992 Abdominal obesity and the metabolic syndrome. Ann Med 24:465-468
38. Kushwaha RS, Hazzard WR 1981 Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 30:359-366
39. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB 1990 Inhibition of coronary artery atherosclerosis by 17-0 estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10:1051-1057
40. Holm P, Andersen HO, Nordestgaard BG, Hansen BF, Kjeldsen K, Stender S 1995 Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas. Atherosclerosis 115:191-200
41. Sulistiyani SJ, Adelman JS, Chandrasekaran A, Rayo J, St. Clair RW 1995 Effects of 17-α-dihydroequilin sulfate, a conjugated equine estrogen and ethylestradiol on atherosclerosis in the rabbit. Atherioscler Thromb Vasc Biol 15:837-846
42. Richelsen B 1997 Action of growth hormone in adipose tissue. Horm Res 5:105-110
43. Costeff H, Holm VA, Ruvalcaba R, Shaver J 1990 Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand 79:1059-1062
44. Ikeda A, Chang KT, Matsumoto Y, Furuhata Y, Nishihara M, Sasaki F, Takahashi M 1998 Obesity and insulin resistance in human growth hormone transgenic rats. Endocrinology 139:3057-3063
45. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L, Bengtsson BA 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 82:727-734
46. Donahue LR, Beamer WG 1993 Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J Endocrinol 136:91-104
47. Oberbauer AM, Runstadler JA, Murray JD, Havel PJ 2001 Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. Obes Res 9:51-58
48. Furuhata Y, Yonezawa T, Takahashi M, Nishihara M 2002 Impaired insulin signaling in the liver of transgenic rats with low circulating growth hormone levels. J Endocrinol 172:127-136
49. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M 2000 Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275:477-480
50. Tolle V, Zizzari P, Tomasetto C, Rio MC, Epelbaum J, Bluet-Pajot MT 2001 In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology 73:54-61
51. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2000 Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23:493-495
52. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K 2000 Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
53. Malik IA, English PJ, Ghatei MA, Bloom SR, MacFarlane IA, Wilding JP 2004 The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol (Oxf) 60:137-141
54. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
55. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
56. Baile CA, McLaughlin CL, Della-Fera MA 1986 Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev 66:172-234
57. Smith GP, Gibbs J 1987 The effect of gut peptides on hunger, satiety, and food intake in humans. Ann NY Acad Sci 499:132-136
58. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR 2002 Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654
59. Kimm SY, Obarzanek E 2002 Childhood obesity: a new pandemic of the new millennium. Pediatrics 110:1003-1007
60. National Research Council 1989 Diet and health. Washington, DC: National Academic Press
61. Pi SF 1993 Medical hazards of obesity. Ann Intern Med 119(7 Pt 2):655-660
62. Hogan S, Fleury A, Hadvary P, Lengsfeld H, Meier MK, Triscari J, Sullivan AC 1987 Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes 11(Suppl 3):35-42
63. Kahn BB, Flier JS 2000 Obesity and insulin resistance. J Clin Invest 106:473-481
64. Reitman ML, Gavrilova O 2000 A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. Int J Obes Relat Metab Disord 24(Suppl 4):S11-S14
65. Franckhauser S, Munoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B, Bosch F 2002 Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 51:624-630
66. Fujiwara T, Ohsawa T, Takahashi S, Ikeda K, Okuno A, Ushiyama S, Matsuda K, Horikoshi H 1998 Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats. Life Sci 63:2039-2047
67. Smith SA, Lister CA, Toseland CD, Buckingham RE 2000 Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Diabetes Obes Metab 2:363-372
68. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
69. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25586
70. Hu E, Liang P, Spiegelman BM 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703
71. Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y, Wang JP, Chen CL, Tai TY, Chuang LM 2002 Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25:376-380
72. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T 2003 Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769
73. Wallace DC 1999 Mitochondrial diseases in man and mouse. Science 283:1482-1488
74. Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB, Piercy V, Carter SA, Lehner I, Smith SA, Beeley LJ, Godden RJ, Herrity N, Skehel M, Changani KK, Hockings PD, Reid DG, Squires SM, Hatcher J, Trail B, Latcham J, Rastan S, Harper AJ, Cadenas S, Buckingham JA, Brand MD, Abuin A 2000 Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406:415-418